Remove Diagnostic Imaging Remove Disease Remove PET Scan
article thumbnail

How Diagnostic Imaging is Revolutionizing Early Disease Detection

Professional Radiology

The Power of Diagnostic Imaging in Early Disease Detection Medical imaging is one of the most significant developments in medical science. By allowing doctors to view the inside of the body without the need for surgery, this technology aids in the early detection of diseases. What is Diagnostic Imaging?

article thumbnail

PSMA-PET superior to MRI in phase II prostate cancer trial

AuntMinnie

"F-18 PSMA-1007 PET/CT provided improved accuracy compared with multiparametric MRI for prostate cancer tumor staging before radical treatment," the group wrote. The diagnosis and management of intermediate-risk and high-risk prostate cancer are increasingly informed by advances in diagnostic imaging, the authors noted.

MRI 264
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Understanding PSMA and Advanced Imaging for Prostate Cancer Detection

TRA Medical Imaging

By using a PET (Positron Emission Tomography) scan with a radiotracer designed to bind to PSMA, this imaging technique allows for highly accurate detection of prostate cancer cells, often identifying disease spread earlier and with more detail than standard imaging methods.

Imaging 59
article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. Traditional treatments didn't slow the disease in these patients, noted UT’s Vroman.

article thumbnail

CMS Proposes Lift of Coverage Restrictions on PET Imaging for Alzheimer's Disease

Diagnostic Imaging

Recognizing the advent of beta amyloid-targeted therapies for the treatment of Alzheimer’s disease, the Centers for Medicare and Medicaid (CMS) has proposed eliminating coverage restrictions that limit amyloid positron emission tomography (PET) scans to clinical trial participants and one amyloid PET scan per lifetime.

Disease 52
article thumbnail

Motor Neurone Disease: Diagnosis and Future Research Insights

Open Medscience

Diagnostic imaging in motor neurone disease (MND) is crucial for early detection, disease monitoring, and differentiating from other conditions. The post Motor Neurone Disease: Diagnosis and Future Research Insights appeared first on Open MedScience.

Disease 52
article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. Traditional treatments didn't slow the disease in these patients, noted UT’s Vroman.